Search hospitals > New York > Rochester

Finger Lakes Clinical Research

Claim this profile
Rochester, New York 14618
Global Leader in Depression
Global Leader in Major Depressive Disorder
Conducts research for Schizophrenia
Conducts research for Bipolar Disorder
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
97 reported clinical trials
1 medical researcher
Photo of Finger Lakes Clinical Research in RochesterPhoto of Finger Lakes Clinical Research in RochesterPhoto of Finger Lakes Clinical Research in Rochester

Summary

Finger Lakes Clinical Research is a medical facility located in Rochester, New York. This center is recognized for care of Depression, Major Depressive Disorder, Schizophrenia, Bipolar Disorder, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Finger Lakes Clinical Research is involved with conducting 97 clinical trials across 48 conditions. There are 1 research doctors associated with this hospital, such as James Whalen, MD.

Top PIs

Clinical Trials running at Finger Lakes Clinical Research

Depression
Major Depressive Disorder
Anhedonia
Adolescent Health
Pediatric Migraine
Schizophrenia
Bipolar Depression
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Image of trial facility.

Aticaprant

for Depression

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepressant (selective serotonin reuptake inhibitor [SSRI] or serotonin and norepinephrine reuptake inhibitor [SNRI]) in all participants with major depressive disorder (MDD).
Recruiting2 awards Phase 316 criteria
Image of trial facility.

Aticaprant

for Major Depressive Disorder

The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving depressive symptoms in adult participants with major depressive disorder (MDD) with moderate-to-severe anhedonia (ANH+) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).
Recruiting1 award Phase 36 criteria
Image of trial facility.

Investigational Drug

for Bipolar Depression

A clinical trial to study the efficacy and safety of an investigational drug in people with major depressive episodes associated with with Bipolar I disorder (bipolar I depression) Participants in the study will either receive the drug being studied or a placebo. The study will be conducted in approximately 90 sites in North America, Europe, Latin America and Japan. It will be have both male and female participants ages 18-65. Participation in the study will be approximately 10 weeks.
Recruiting1 award Phase 35 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Finger Lakes Clinical Research?
Finger Lakes Clinical Research is a medical facility located in Rochester, New York. This center is recognized for care of Depression, Major Depressive Disorder, Schizophrenia, Bipolar Disorder, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Finger Lakes Clinical Research is involved with conducting 97 clinical trials across 48 conditions. There are 1 research doctors associated with this hospital, such as James Whalen, MD.